Driver Ian D, Wise Richard G, Murphy Kevin
Cardiff University Brain Research Imaging Centre, School of Psychology, Cardiff UniversityCardiff, United Kingdom.
School of Physics and Astronomy, Cardiff UniversityCardiff, United Kingdom.
Front Neurosci. 2017 May 18;11:276. doi: 10.3389/fnins.2017.00276. eCollection 2017.
Calibrated BOLD is a promising technique that overcomes the sensitivity of conventional fMRI to the cerebrovascular state; measuring either the basal level, or the task-induced response of cerebral metabolic rate of oxygen consumption (CMRO). The calibrated BOLD method is susceptible to errors in the measurement of the calibration parameter , the theoretical BOLD signal change that would occur if all deoxygenated hemoglobin were removed. The original and most popular method for measuring uses hypercapnia (an increase in arterial CO), making the assumption that it does not affect CMRO. This assumption has since been challenged and recent studies have used a corrective term, based on literature values of a reduction in basal CMRO with hypercapnia. This is not ideal, as this value may vary across subjects and regions of the brain, and will depend on the level of hypercapnia achieved. Here we propose a new approach, using a graded hypercapnia design and the assumption that CMRO changes linearly with hypercapnia level, such that we can measure without assuming prior knowledge of the scale of CMRO change. Through use of a graded hypercapnia gas challenge, we are able to remove the bias caused by a reduction in basal CMRO during hypercapnia, whilst simultaneously calculating the dose-wise CMRO change with hypercapnia. When compared with assuming no change in CMRO, this approach resulted in significantly lower -values in both visual and motor cortices, arising from significant dose-dependent hypercapnia reductions in basal CMRO of 1.5 ± 0.6%/mmHg (visual) and 1.8 ± 0.7%/mmHg (motor), where mmHg is the unit change in end-tidal CO level. Variability in the basal CMRO response to hypercapnia, due to experimental differences and inter-subject variability, is accounted for in this approach, unlike previous correction approaches, which use literature values. By incorporating measurement of, and correction for, the reduction in basal CMRO during hypercapnia in the measurement of -values, application of our approach will correct for an overestimation in both CMRO task-response values and absolute CMRO.
校准后的血氧水平依赖(BOLD)是一种很有前景的技术,它克服了传统功能磁共振成像(fMRI)对脑血管状态的敏感性;可测量脑氧代谢率(CMRO₂)的基础水平或任务诱发反应。校准后的BOLD方法易受校准参数测量误差的影响,校准参数是指如果所有脱氧血红蛋白都被去除时理论上会发生的BOLD信号变化。测量校准参数的最初且最常用的方法是使用高碳酸血症(动脉血二氧化碳分压升高),并假设其不影响CMRO₂。此假设后来受到了质疑,最近的研究使用了一个校正项,该校正项基于文献中高碳酸血症导致基础CMRO₂降低的值。这并不理想,因为该值可能因受试者和脑区而异,并且将取决于所达到的高碳酸血症水平。在此,我们提出一种新方法,使用分级高碳酸血症设计,并假设CMRO₂随高碳酸血症水平呈线性变化,这样我们就可以在不假设事先知晓CMRO₂变化幅度的情况下测量校准参数。通过使用分级高碳酸血症气体激发,我们能够消除高碳酸血症期间基础CMRO₂降低所导致的偏差,同时计算随高碳酸血症剂量变化的CMRO₂变化。与假设CMRO₂无变化相比,这种方法在视觉和运动皮层中均导致显著更低的校准参数值,这是由于基础CMRO₂出现显著的剂量依赖性降低,视觉皮层为1.5±0.6%/mmHg,运动皮层为1.8±0.7%/mmHg,其中mmHg是呼气末二氧化碳水平的单位变化量。与之前使用文献值的校正方法不同,这种方法考虑了由于实验差异和个体间变异性导致的基础CMRO₂对高碳酸血症反应的变异性。通过在校准参数值测量中纳入对高碳酸血症期间基础CMRO₂降低的测量和校正,我们的方法应用将校正CMRO₂任务反应值和绝对CMRO₂的高估。